XGNExagen Inc.Healthcare · Medical - Diagnostics & Researchas of 2026-09-16
Horizon

Issued 2026-09-16 at $7.78 · now $7.78 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, XGN has typically landed between $5.42 and $11.45 — a range of −30.3% to +47.1% from the issuance price $7.78.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.
  • Actual close
  • Typical path (median)
  • Middle 50% of outcomes
  • 90% range

1,735 overlapping 1 month windows · 2019-09-192026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.756.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($7.78) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

Where XGN has typically landed a month from the 2026-09-16 close of $7.78 — the range is history, not a prediction.

$5.42worst · -30.3%$11.45best · +47.1%
  • now $7.78 (+0.0%)
  • typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $7.59 (-2.4%)
  • middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $6.48$8.71
  • 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $5.42$11.45
Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 1,735 windows spanning 2019-09-19 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.
StartReturnMax dropMax rise
3 worst
2022-07-25−49.3%−49.5%+0.0%
2022-09-15−48.7%−48.7%+0.0%
2024-12-13−47.1%−48.1%+3.8%
3 best
2024-11-13+110.2%+0.0%+110.2%
2024-11-14+106.9%+0.0%+106.9%
2024-11-12+105.4%−1.4%+105.4%

1,735 overlapping windows · 2019-09-192026-09-16 · not cherry-picked

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~7 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.
Jan
43%
−4.4%
n=7
Feb
29%
−6.3%
n=7
Mar
29%
−7.5%
n=7
Apr
29%
+4.6%
n=7
May
57%
+11.8%
n=7
Jun
57%
+1.5%
n=7
Jul
57%
+2.6%
n=7
Aug
86%
+18.6%
n=7
Sep
43%
−7.3%
n=7
Oct
29%
−5.7%
n=7
Nov
71%
+8.6%
n=7
Dec
57%
+3.1%
n=7

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Share price & reported tradesMonthly open-market valueReporting lag — trade date to filing date2026-092026-082026-072026-062026-052026-042026-032026-022026-012025-122025-112025-102025-092025-08$12$32026-09-01: 1 insider sale, $149K — Black Jeffrey G.2026-03-03: 1 insider sale, $57K — ABALLI JOHN2026-02-24: 2 insider sales, $47K — ABALLI JOHN, Black Jeffrey G.2025-10-16: 1 insider sale, $376K — ABALLI JOHN2025-09-02: 1 insider sale, $200K — Black Jeffrey G.2025-09: 1 open-market sale, $200K2025-10: 1 open-market sale, $376K2026-02: 2 open-market sales, $47K2026-03: 1 open-market sale, $57K2026-09: 1 open-market sale, $149K↑ buys↓ salesofficer Black Jeffrey G. — Sale on 2026-09-01, filed 1 day after the tradedirector ABALLI JOHN — Sale on 2026-03-03, filed 1 day after the tradedirector ABALLI JOHN — Sale on 2026-02-24, filed 1 day after the tradeofficer Black Jeffrey G. — Sale on 2026-02-24, filed 1 day after the tradedirector ABALLI JOHN — Sale on 2025-10-16, filed 4 days after the tradeofficer Black Jeffrey G. — Sale on 2025-09-02, filed 2 days after the trade
DatePersonRoleActionShares @ priceValueOwnership Δvs S&P 1mvs S&P 6mOwned afterFiling
2026-09-01Black Jeffrey G.officerSale20,614 @ $7.22$149K−6.0% of holdingnot yet — horizon still opennot yet — horizon still open323,339Form 4 · filed 1 day after the trade
2026-03-03ABALLI JOHNdirectorSale15,698 @ $3.62$57K−2.2% of holding−8.8%+95.0%687,299Form 4 · filed 1 day after the trade
2026-02-24ABALLI JOHNdirectorSale11,430 @ $3.61$41K−1.6% of holding−17.8%+93.9%702,997Form 4 · filed 1 day after the trade
2026-02-24Black Jeffrey G.officerSale1,584 @ $3.61$6K−0.6% of holding−17.8%+93.9%267,442Form 4 · filed 1 day after the trade
2025-10-16ABALLI JOHNdirectorSale31,787 @ $11.82$376K−4.3% of holding−25.2%−82.5%714,427Form 4 · filed 4 days after the trade
2025-09-02Black Jeffrey G.officerSale20,466 @ $9.79$200K−7.1% of holding+9.6%−70.3%269,026Form 4 · filed 2 days after the trade
2025-03-25NMSIC Co-Investment Fund, L.P.tenPercentOwnerSale350,000 @ $3.30$1.2M−16.6% of holding+56.6%+163.7%1,758,958Form 4 · filed 2 days after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

22 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

DatePersonRoleActionSharesOwned afterFiling
2026-09-01Black Jeffrey G.officerAward / grant1,571324,910Form 4
2026-06-09McKhann ChasdirectorAward / grant37,50045,000Form 4
2026-06-09KAHN SCOTT DdirectorAward / grant37,50046,500Form 4
2026-06-09Stokes FrankdirectorAward / grant37,500112,500Form 4
2026-06-09Kim PauldirectorAward / grant37,50046,500Form 4
2026-06-09Robertson Bruce CdirectorAward / grant37,50055,500Form 4
2026-03-12ABALLI JOHNdirectorAward / grant100,000175,000Form 4
2026-03-12Black Jeffrey G.officerAward / grant75,000342,442Form 4
2026-03-12Black Jeffrey G.officerAward / grant50,00060,000Form 4
2026-03-12ABALLI JOHNdirectorAward / grant150,000839,834Form 4
2026-03-03ABALLI JOHNdirectorAward / grant2,535689,834Form 4
2026-02-27Black Jeffrey G.officerAward / grant1,511343,953Form 4
2025-06-10KAHN SCOTT DdirectorAward / grant9,0009,000Form 4
2025-06-10Kim PauldirectorAward / grant9,00018,000Form 4
2025-06-10Hooker AnadirectorAward / grant9,0009,000Form 4
2025-06-10Nova Tina SusandirectorAward / grant13,50013,500Form 4
2025-06-10Stokes FrankdirectorAward / grant9,0009,000Form 4
2025-02-28ABALLI JOHNdirectorAward / grant8,621746,214Form 4
2025-02-21ABALLI JOHNdirectorAward / grant75,00075,000Form 4
2025-02-21Black Jeffrey G.officerAward / grant10,00010,000Form 4
2025-02-21ABALLI JOHNdirectorAward / grant112,500737,593Form 4
2025-02-21Black Jeffrey G.officerAward / grant15,000289,492Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.